FAKTOR-OPTIONSSCHEIN - GETINGE B Share Price

Certificat

DE000MG2Y294

Real-time Bid/Ask 09:12:15 17/06/2024 BST
32.94 EUR / 33.34 EUR +23.70% Intraday chart for FAKTOR-OPTIONSSCHEIN - GETINGE B
Current month+7.76%
1 month+123.06%
Date Price Change
14/06/24 26.79 -8.54%
13/06/24 29.29 +5.51%
12/06/24 27.76 +1.39%
11/06/24 27.38 -2.98%
10/06/24 28.22 +19.58%

Delayed Quote Börse Stuttgart

Last update June 14, 2024 at 12:16 pm

More quotes

Static data

Product typeProduits Exotiques
Buy / SellCALL
Underlying GETINGE AB
Issuer Morgan Stanley
WKN MG2Y29
ISINDE000MG2Y294
Date issued 24/04/2024
Strike 205.6 kr
Maturity Unlimited
Parity 0.07 : 1
Emission price 10
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 29.76
Lowest since issue 6.57
Spread 0.4
Spread %1.20%

Company Profile

Getinge AB is the world's leader in producing and marketing medical equipment intended to health care facilities (clinics, hospitals, rest homes, etc.). Net sales break down by family of products as follows: - medical systems (57.4%): equipment for operating rooms (primarily tables and lighting systems), ventilators and heart and lung machines, etc.; - hospital sterilization equipment (29.4%); - contamination prevention equipment (13.2%): in the fields of biopharmaceutical production, biomedical research, manufacturing of medical devices and laboratory applications. Net sales break down by source of income into sales of equipment (45.3%), consumables (37.1%), services and spare parts (17.6%). At the end of 2021, the group had 20 production sites worldwide. Net sales are distributed geographically as follows: Sweden (1.8%), Europe/Middle East/Africa (35.8%), Americas (37.9%) and Asia/Pacific (24.5%).
Sector
-
More about the company

Ratings for Getinge AB

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Getinge AB

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
182.8 SEK
Average target price
231.9 SEK
Spread / Average Target
+26.85%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW